Document Preview Unavailable
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study)
Sepe Pierangela; Procopio Giuseppe; Pircher, Chiara Carlotta; Basso Umberto; Caffo Orazio; et al. Therapeutic Advances in Medical Oncology Vol. 16, (Jan 2024).You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library